ESCRS - Treating uveitis in children ;

Treating uveitis in children

Many challenges of diagnosis and treatment of paediatric uveitis

Treating uveitis in children
Dermot McGrath
Dermot McGrath
Published: Tuesday, October 1, 2019
[caption id="attachment_16838" align="alignleft" width="1024"] Posterior synechia secondary to HLA B27 anterior uveitis[/caption] Rapid diagnosis and swift intervention with targeted treatments is essential to reduce the risk of vision-threatening complications in cases of paediatric uveitis, according to Marie-Hélène Errera MD, PhD. “These cases in children are typically chronic and may result in substantial ocular complications and vision loss if they are not diagnosed and treated appropriately,” she told delegates attending a World Society of Paediatric Ophthalmology and Strabismus (WSPOS) symposium held during the European Society of Ophthalmology (SOE) meeting in Nice, France. The differential diagnosis of paediatric uveitis is extensive, noted Dr Errera, associate professor of ophthalmology at UPMC Eye Center, Children’s hospital Pittsburgh and at the University of Pittsburgh School of Medicine, Pennsylvania, United States. As in adult patients, it is important to identify infectious versus non-infectious uveitis as well as anatomic location, since that will have a bearing on prognosis and treatment strategies, she said. “Of non-infectious causes, juvenile idiopathic arthritis (JIA) is the most common systemic association of paediatric uveitis and accounts for between 35% and 60% of uveitis cases in children,” she said. Pars planitis is another common idiopathic intermediate uveitis, which predominantly affects children and adolescents, and accounts for up to 28% of paediatric uveitis cases. “Complications to watch for with pars planitis include cataract, cystoid macular oedema, vitreous opacities, glaucoma, retinoschisis, retinal detachment, epiretinal membrane and optic disc oedema.” Other autoimmune causes of paediatric uveitis include juvenile sarcoidosis and Blau syndrome, which may also present with joint and eye involvement. Both of these conditions usually present with granulomatous ocular inflammation and can have posterior segment involvement, which is not normally found in JIA-related uveitis, she added.
Juxtapapillary retinochoroiditis and macular star related to toxoplasmosis in a 12-year-old child
Toxoplasmosis, caused by the parasite Toxoplasma gondii, is the most common cause of posterior uveitis in children and adults, said Dr Errera. It is normally unilateral and ocular manifestations include retinochoroiditis and retinal vasculitis, which can be challenging to diagnose and treat. Sarcoidosis, a rare disease characterised by the formation of granulomas in different tissues and organs throughout the body, presents in two distinct forms in children. “In children under the age of 5 there are usually three features present – a rash, arthritis and uveitis. In older children, the lungs, lymph nodes and eyes are affected,” she said. Tubulointerstitial Nephritis and uveitis (TINU) is rare and possibly underdiagnosed. It presents as a sudden-onset bilateral AU in older children to young adults. Topical corticosteroids such as prednisolone or dexamethasone remain the first-line treatment for both acute and chronic anterior uveitis, said Dr Errera, while in severe cases immunosuppressive and biological agents may be used. The use of anti-TNF treatments such as adalimumab and infliximab may also be proposed in JIA-related uveitis refractory to conventional therapy, but also tocilizumab, abatacept and rituximab, concluded Dr Errera. Marie-Hélène Errera: erreram@upmc.edu
Tags: uveitis
Latest Articles
ESCRS Research Projects Make a Difference

EPICAT study continues tradition of practice-changing clinical studies.

Read more...

Tablao Debates: Cataract-Refractive Edition

Lively debate format pairs EDOF lenses with trifocals in a dance for first prize in surgery choice.

Read more...

Phakic IOLs for Myopia and Presbyopia

Many options for patients under age 60.

Read more...

Effect of COVID-19 and Vaccine on Retinal Disease

Registry-based studies indicate risk for retinal vascular occlusions have not increased.

Read more...

ESCRS Accepting Applications for Peter Barry Fellowship

Read more...

Setting Limits for PRK and LASIK

Clinical evaluation and personal judgment come into play.

Read more...

Advances in Adaptive Optics

New tools allow better preoperative prediction and greater customisation.

Read more...

Real-World Strategies for New Tech Adoption

Step by step real-world experience shows improvement in clinical outcomes.

Read more...

Going Beyond Cataract Camps

ESCRS expanding treatment opportunities in underserved areas.

Read more...

Bridging the Gap Between Local and Global

New training programmes seek to reach hard-to-reach areas to meet growing patient needs.

Read more...